Singapur - anglès - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - raltegravir potassium 27.16 mg eqv raltegravir - tablet, chewable - 25 mg - raltegravir potassium 27.16 mg eqv raltegravir 25 mg

Singapur - anglès - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - carbamazepine - tablet - 200 mg - carbamazepine 200 mg

Singapur - anglès - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - carbamazepine - tablet, film coated - 200 mg - carbamazepine 200 mg

Singapur - anglès - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - carbamazepine - tablet, film coated - 400 mg - carbamazepine 400 mg

Singapur - anglès - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - carbamazepine - suspension - 2 g/100 ml - carbamazepine 2 g/100 ml

Aràbia Saudita - anglès - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

janssen-cilag international nv, belgium - ad26 cov2s - suspension for injection - 1000000000 vector genomes/ml

Estats Units - anglès - NLM (National Library of Medicine)

piramal critical care, inc. - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane 1 ml in 1 ml - isoflurane may be used for induction and maintenance of general anesthesia. adequate data have not been developed to establish its application in obstetrical anesthesia. isoflurane is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to isoflurane or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia (see warnings /malignant hyperthermia, clinical pharmacology / pharmacogenomics). • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics.

Estats Units - anglès - NLM (National Library of Medicine)

piramal critical care inc - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane 1 ml in 1 ml - isoflurane may be used for induction and maintenance of general anesthesia. adequate data have not been developed to establish its application in obstetrical anesthesia. isoflurane is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to isoflurane or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia (see warnings /malignant hyperthermia, clinical pharmacology / pharmacogenomics). • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics.

Estats Units - anglès - NLM (National Library of Medicine)

piramal critical care inc - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane may be used for induction and maintenance of general anesthesia. adequate data have not been developed to establish its application in obstetrical anesthesia. isoflurane is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to isoflurane or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia (see warnings /malignant hyperthermia, clinical pharmacology / pharmacogenomics). • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics.

Estats Units - anglès - NLM (National Library of Medicine)

piramal critical care inc - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane may be used for induction and maintenance of general anesthesia. adequate data have not been developed to establish its application in obstetrical anesthesia. isoflurane is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to isoflurane or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia (see warnings /malignant hyperthermia, clinical pharmacology / pharmacogenomics). • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics